Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Garrett Motion Inc. Common Stock (GTX) Price & Performance

GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.

The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.

Garrett Motion (GTX) trades at $25.78, showing minimal daily movement with a 0.08% gain. The stock exhibits bearish technical signals despite strong fundamental performance, including three consecutive quarterly earnings beats and improving profit margins. Recent news highlights the company's leadership in turbocharging and electrification technologies, with Q3 2026 results expected on October 29th. Institutional activity shows significant positions from BlackRock and Deutsche Bank, while analyst consensus remains positive with a $38 price target representing 47% upside potential.

GTX presents a compelling value opportunity with attractive valuation multiples (P/E 14.16, P/S 1.35) and consistent earnings outperformance. However, technical weakness and competitive pressures in automotive technology create near-term headwinds. The upcoming Q3 earnings report on October 29th will be crucial for validating the company's raised 2026 outlook and momentum trajectory.